共 50 条
The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned
被引:8
作者:
Katato, Ghadir K. K.
[1
,2
]
Sitaula, Prasiksha
[1
,2
]
Gupte, Avanti
[1
,2
,3
]
Al-Antary, Eman T. T.
[1
,2
,3
]
机构:
[1] Childrens Hosp Michigan, Div Hematol Oncol, Detroit, MI 48201 USA
[2] Cent Michigan Univ, Dept Pediat, Coll Med, Mt Clemons, MI 48603 USA
[3] Childrens Hosp Michigan, Barbara Ann Karmanos Canc Ctr, Pediat Blood & Marrow Transplantat Program, Div Hematol Oncol, Detroit, MI 48201 USA
来源:
关键词:
COVID-19;
oncology;
pediatric;
epidemiology;
management;
diagnosis;
ACUTE MYELOID-LEUKEMIA;
HODGKIN LYMPHOMA;
CANCER CARE;
CHILDREN;
MORTALITY;
OUTCOMES;
DISEASE;
ABVD;
D O I:
10.3390/vaccines11030667
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic affected the pediatric oncology population globally. Over the course of 2 years, increasing reports have been made to better understand this entity and its pathologic complications on these patients. The pandemic has allowed healthcare providers, hospital systems, and leading oncologic societies to quickly adapt and formulate new guidelines for the effective understanding, management, and treatment of patients with pediatric malignancy.
引用
收藏
页数:15
相关论文
共 50 条